Profil
Chen Zong is currently President at Harbour BioMed (Shanghai) Co., Ltd. and President at HBM Holdings Ltd., both positions starting in 2026.
Formerly, Dr. Zong was President & Chief Operating Officer at Seven & Eight Biopharmaceuticals, Inc. Education includes a doctorate from The Rockefeller University and an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Adam Zong
| Sociétés | Poste | Début |
|---|---|---|
| HBM HOLDINGS LIMITED | President | 16/04/2026 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | President | 16/04/2026 |
Anciens postes connus de Adam Zong
| Sociétés | Poste | Fin |
|---|---|---|
Seven & Eight Biopharmaceuticals, Inc.
Seven & Eight Biopharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of novel immunotherapies for cancer | President | - |
Formation de Adam Zong
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Health Technology |
HBM Holdings Ltd.
HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
Seven & Eight Biopharmaceuticals, Inc.
Seven & Eight Biopharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of novel immunotherapies for cancer | Health Technology |
















